Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.4700
+0.0300 (6.82%)
At close: Oct 30, 2026
Bio Essence Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 25 | 2 | 9 | 19 | 18 | - | |
Market Cap Growth | 868.52% | -75.10% | -52.74% | 6.77% | - | - |
Enterprise Value | 27 | 5 | 12 | 23 | 23 | - |
Last Close Price | 0.47 | 0.06 | 0.24 | 0.51 | 0.55 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.77 | 2.55 | - | - | - | - |
PS Ratio | 8.69 | 1.20 | 28.28 | - | 29.21 | - |
PB Ratio | 10.80 | -1.10 | -3.08 | -11.67 | -5.61 | - |
P/FCF Ratio | 23.51 | 1.45 | 14.68 | - | - | - |
P/OCF Ratio | 23.51 | 1.45 | 14.68 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 9.22 | 2.47 | 37.88 | - | 36.47 | - |
EV/EBITDA Ratio | 16.12 | 5.21 | - | - | - | - |
EV/EBIT Ratio | 17.45 | 5.21 | - | - | - | - |
EV/FCF Ratio | 24.97 | 2.99 | 19.67 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.67 | -0.75 | -0.91 | -1.98 | -1.43 | -1.63 |
Debt / EBITDA Ratio | 0.94 | 1.66 | - | - | - | - |
Debt / FCF Ratio | 1.46 | 1.00 | 4.34 | - | - | - |
Net Debt / Equity Ratio | 0.67 | -0.75 | -0.91 | -1.98 | -1.42 | -1.63 |
Net Debt / EBITDA Ratio | 0.95 | 1.74 | -5.90 | -9.65 | -9.29 | -4.82 |
Net Debt / FCF Ratio | 1.46 | 1.00 | 4.34 | -3.20 | -6.52 | -2.80 |
Asset Turnover | 1.42 | 5.40 | 0.21 | - | 0.38 | 0.50 |
Inventory Turnover | - | - | - | - | 1.49 | 2.43 |
Quick Ratio | 0.00 | 0.01 | 0.00 | - | 0.00 | 0.01 |
Current Ratio | 0.38 | 0.17 | 0.10 | 0.12 | 0.06 | 0.10 |
Return on Assets (ROA) | 46.74% | 159.92% | -18.89% | -10.03% | -19.68% | -30.24% |
Return on Invested Capital (ROIC) | 119.67% | - | - | - | - | - |
Return on Capital Employed (ROCE) | 64.20% | -44.60% | 18.20% | -112.20% | 25.40% | 81.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 7.26% | 39.30% | -14.29% | -5.01% | -4.46% | - |
FCF Yield | 4.25% | 68.83% | 6.81% | -5.31% | -3.89% | - |
Buyback Yield / Dilution | -16.94% | - | -11.94% | -2.86% | - | 0.08% |